Cargando…

Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis

CONTEXT: To systematically evaluate the effects of hepatoprotective agents, when delivered either alone or in combination with other antiviral or non-antiviral drugs in patients with hepatitis B and hepatic fibrosis. OBJECTIVES: The current randomized controlled clinical trials aimed to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Li-Hui, Xue, Cai-Qin, Shi, Jun-Feng, Dong, Juan-Ni, Wang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539848/ https://www.ncbi.nlm.nih.gov/pubmed/26300933 http://dx.doi.org/10.5812/hepatmon.29052v2

Ejemplares similares

Hepatoprotective and Antiviral Efficacy of Acacia mellifera Leaves Fractions against Hepatitis B Virus
por: Arbab, Ahmed H., et al.
Publicado: (2015)

Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
por: Chen, Xiao-Feng, et al.
Publicado: (2022)

Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis
por: Miao, Liang, et al.
Publicado: (2023)

Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice
por: Luangmonkong, Theerut, et al.
Publicado: (2023)

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018)

Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis
por: Gao, Hong-Ying, et al.
Publicado: (2012)

Investigating the hepatoprotective potentiality of marine-derived steroids as promising inhibitors of liver fibrosis
por: Tammam, Mohamed A., et al.
Publicado: (2023)

Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs
por: Zhou, Yongfeng, et al.
Publicado: (2021)

Hepatoprotective effect of Herpetospermum caudigerum Wall. on carbon tetrachloride‐induced hepatic fibrosis in rats
por: Feng, Xin, et al.
Publicado: (2018)

Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents
por: Cossiga, Valentina, et al.
Publicado: (2022)

Assessment of Hepatic Fibrosis Regression by Transient Elastography in Patients with Chronic Hepatitis B Treated with Oral Antiviral Agents
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure)
por: Ning, Qin, et al.
Publicado: (2019)

Hepatoprotective Effect of MMP-19 Deficiency in a Mouse Model of Chronic Liver Fibrosis
por: Jirouskova, Marketa, et al.
Publicado: (2012)

PASS-Predicted Hepatoprotective Activity of Caesalpinia sappan in Thioacetamide-Induced Liver Fibrosis in Rats
por: Kadir, Farkaad A., et al.
Publicado: (2014)

New Antiviral Agents for Hepatitis C
por: Pawlotsky, Jean-Michel
Publicado: (2012)

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
por: Toshikuni, Nobuyuki
Publicado: (2017)

Diagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysis
por: Mingkai, Li, et al.
Publicado: (2022)

Efficacy and safety of anti-hepatic fibrosis drugs
por: Damiris, Konstantinos, et al.
Publicado: (2020)

Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
por: Yoo, Hae Won, et al.
Publicado: (2022)

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Hepatoprotective Role of Ethanolic Extract of Vitex negundo in Thioacetamide-Induced Liver Fibrosis in Male Rats
por: Kadir, Farkaad A., et al.
Publicado: (2013)

Retracted: PASS-Predicted Hepatoprotective Activity of Caesalpinia sappan in Thioacetamide-Induced Liver Fibrosis in Rats
por: The Scientific World Journal,
Publicado: (2018)

Hepatoprotective Evaluation of Trapa natans against Drug-induced Hepatotoxicity of Antitubercular Agents in Rats
por: Hussain, Talib, et al.
Publicado: (2018)

Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C
por: Gao, Lu-Hua, et al.
Publicado: (2021)

Hepatoprotective effect of juglone on dimethylnitrosamine-induced liver fibrosis and its effect on hepatic antioxidant defence and the expression levels of α-SMA and collagen III
por: ZHOU, DE-JIANG, et al.
Publicado: (2015)

Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series
por: Patauner, Fabian, et al.
Publicado: (2022)

Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective study
por: Li, Juan, et al.
Publicado: (2020)

Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injury
por: Tan, Cheau Yih, et al.
Publicado: (2015)

Direct-Acting Antiviral Treatment in Albanian Patients With Chronic Hepatitis C and Advanced Liver Fibrosis
por: Cuko, Liri, et al.
Publicado: (2022)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
por: Mu, Li-ya, et al.
Publicado: (2021)

Corrigendum to “Hepatoprotective Role of Ethanolic Extract of Vitex negundo in Thioacetamide-Induced Liver Fibrosis in Male Rats”
por: Kadir, Farkaad A., et al.
Publicado: (2018)

Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
por: El-Gendy, Zeinab A., et al.
Publicado: (2021)

Hepatoprotective Effect of Opuntia robusta Fruit Biocomponents in a Rat Model of Thioacetamide-Induced Liver Fibrosis
por: Pulido-Hornedo, Nayeli Amalinalli, et al.
Publicado: (2022)

Hepatoprotective and antifibrotic effects of trans-chalcone against bile duct ligation-induced liver fibrosis in rats
por: Javadi, Faezeh, et al.
Publicado: (2023)

The Hepatoprotective Effect of Haoqin Qingdan Decoction against Liver Injury Induced by a Chemotherapeutic Drug Cyclophosphamide
por: Li, Xiaojiang, et al.
Publicado: (2015)

Hepatoprotective agent tethered isoniazid for the treatment of drug-induced hepatotoxicity: Synthesis, biochemical and histopathological evaluation
por: Singh, Charan, et al.
Publicado: (2014)

Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon-Tetrachloride-Induced Liver Fibrosis in Rats
por: Yin, Kehuan, et al.
Publicado: (2021)

Fibrosis regression following hepatitis C antiviral therapy
por: Elsharkawy, Aisha, et al.
Publicado: (2022)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gggn6n5saic6v8trh33m4rcfld